Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
BRCA1 Antibody (17F8), Novus Biologicals™

Mouse Monoclonal Antibody
Supplier: Novus Biologicals NBP141185
Description
BRCA1 Monoclonal specifically detects BRCA1 in Human, Mouse samples. It is validated for Western Blot, Chromatin Immunoprecipitation, ELISA, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunoprecipitation, Immunohistochemistry-Paraffin.Specifications
BRCA1 | |
Monoclonal | |
1.0mg/mL | |
Western Blot 1:500-1:3000, ELISA, Immunohistochemistry, Immunocytochemistry/Immunofluorescence 1 ug/ml, Immunoprecipitation, Immunohistochemistry-Paraffin, Chromatin Immunoprecipitation (ChIP) 1:10-1:500 | |
BRCA1 | |
Protein fragment expressed in E. coli corresponding to amino acids 762-1315. | |
Protein G purified | |
RUO | |
Primary | |
This antibody does not recognize the delta exon 11 splice variant of BRCA1. In a high proportion of breast and ovarian cancer cell lines, BRCA1 aberrantly mislocates to the cytoplasm. | |
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles. | |
IgG1 |
Western Blot, ELISA, Immunohistochemistry, Immunocytochemistry, Immunofluorescence | |
17F8 | |
Unconjugated | |
BRCAI, breast and ovarian cancer susceptibility protein 1, breast and ovarian cancer sususceptibility protein, breast cancer 1, early onset, breast cancer type 1 susceptibility protein, EC 6.3.2, EC 6.3.2.-, IRIS, PNCA4, PSCP, subunit 1 | |
Mouse | |
220 kDa | |
100 μL | |
Apoptosis, Breast Cancer, Cancer, Cell Biology, Chromatin Research, DNA Double Strand Break Repair, DNA Repair, Homologous Recombination, Tumor Suppressors, Ubiquitin Proteasome Pathway, Zinc Finger | |
672 | |
Human, Mouse | |
Purified |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction